Golotimod
Golotimod (SCV-07), an immunomodulating peptide with antimicrobial activity, significantly increases the efficacy of antituberculosis therapy, stimulates thymic and splenic cell proliferation, and improves macrophage function. Golotimod (SCV-07) inhibits STAT3 signaling and modulates the duration and severity of oral mucositis in animal models that received radiation or a combination of radiation and Cisplatin. Golotimod (SCV-07) is also a potential therapeutic for recurrent genital herpes simplex virus type 2 (HSV-2) [1][2][3].
Product Specifications
CAS Number
229305-39-9
Product Name Alternative
SCV 07; Gamma-D-glutamyl-L-tryptophan
UNSPSC
12352209
Target
Bacterial; STAT
Type
Reference compound
Related Pathways
Anti-infection; JAK/STAT Signaling; Stem Cell/Wnt
Applications
COVID-19-anti-virus
Field of Research
Infection; Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/golotimod.html
Purity
98.04
Solubility
DMSO : 50 mg/mL (ultrasonic) |H2O : 125 mg/mL (ultrasonic)
Smiles
O=C(CC[C@@](N)(C(O)=O)[H])N[C@]([H])(C(O)=O)CC1=CNC2=C1C=CC=C2
Molecular Formula
C16H19N3O5
Molecular Weight
333.34
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
STAT3
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cyclin D2 (CCND2/2620), CF640R conjugate, 0.1mg/mL
CD21 (Mature B-Cell & Follicular Dendritic Cell Marker) (CR2/1953), CF740 conjugate, 0.1mg/mL
